Objective: To examine the effects of sugar beet pectin (SBP) and polydextrose (PDX) on fasting plasma glucose concentration, serum lipid profile and postprandial glycemia in middle-aged subjects with abnormal glucose metabolism. Design: A placebo-controlled, randomized, parallel double-blinded study. Subjects and setting: Subjects were recruited via newspaper announcements. Seventy subjects were recruited of which 66 completed the study. Intervention: The intervention period lasted for 12 weeks during which the subjects consumed a drink enriched with either SBP (n ¼ 22) or PDX (n ¼ 22) or without fiber enrichment (control group, n ¼ 22). The daily dose of the drinks was 4 dl. The subjects were also given nutrition counseling. Postprandial glycemia was examined in 24 subjects (n ¼ 8 in each group) at 0 and 12 weeks after a standardized breakfast. Results: Fasting plasma glucose concentration did not change in the SBP and PDX groups, whereas it increased in the control group (P ¼ 0.007). On the contrary, the glycosylated hemoglobin A1 c increased marginally but significantly (Pp0.05) in the intervention groups without a change in the control group. In postprandial glycemia, no differences between the groups were found. In both the SBP and PDX groups, fasting serum High-density lipoprotein (HDL)-cholesterol concentration increased (Pp0.05) without a change in the control group. Total to HDL-cholesterol ratio decreased in all groups (Pp0.05). Conclusions: It was found that SBP and PDX do not have positive effects on fasting or postprandial plasma glucose concentrations or serum lipid profile in subjects with abnormal glucose metabolism. Sponsorship:
Introduction
Type 2 diabetes mellitus (DM2) is becoming to one of the major causes of clinical and public health problems around the world. It has been predicted that there will be at least 350 million people in the world with type 2 diabetes by the year 2030 (WHO, 2003) . Type 2 diabetes mellitus is a disease, that usually develops gradually through impaired glucose tolerance (IGT). A person with a high risk of developing DM2 has several characteristics of metabolic syndrome, that is, central obesity, elevated blood pressure, and low serum High-density lipoprotein (HDL)-cholesterol and elevated serum triglyceride concentrations. Furthermore, the disease has a strong genetic background, but sedentary lifestyle and increasing prevalence of obesity largely explain the current epidemic of DM2. Type 2 diabetes mellitus increases markedly the risk of cardiovascular diseases. Research into primary prevention should thus not only focus on impaired glucose metabolism, but also on obesity, blood pressure and serum lipid concentrations.
Three recent long-term lifestyle intervention trials have shown that it is possible to prevent or delay the development of DM2 by changing lifestyles. In the Finnish Diabetes Prevention Study, besides weight reduction and physical activity also an increased intake of dietary fiber and a modification of the quality of dietary fat contributed to risk reduction (Tuomilehto et al., 2001; Lindström et al., 2003) .
The study by Chandalia et al. (2000) showed a beneficial effect of dietary fiber on glucose homeostasis in subjects with DM2. Intake of soluble fiber has been shown to improve postprandial glucose metabolism, and guar gum, a soluble fiber, has been shown to improve glucose concentrations in DM2 patients (Aro et al., 1981; Fuessl et al., 1987; Groop et al., 1993) .
The aim of the study was to examine the effects of sugar beet pectin (SBP) and polydextrose (PDX) as a part of the daily diet on fasting concentrations of plasma glucose and serum total and lipoprotein lipids as well as on postprandial glycemia in middle-aged subjects with abnormal glucose metabolism (IGT, impaired fasting glucose (IFG) or diettreated DM2).
Subjects and methods

Subjects
Seventy subjects (31 male and 39 female subjects) with normal liver, kidney and thyroid functions were recruited for the study. Two of the subjects dropped out at the very beginning of the study, one owing to lack of motivation and the other owing to skin problems with unknown etiology. Two subjects dropped out at the very end of the study, one owing to excessive alcohol intake at the very end of the study and one owing to scheduling problems. Therefore, the final number of subjects was 66 (29 male and 37 female subjects) of which 10 had diet-treated DM2. Seventeen of the subjects had hypertension and five reported to have gallstones. Forty subjects were on a regular medication (antihypertensive medication, postmenopausal hormonal replacement therapy). The subjects were asked to keep their medication constant during the study. The subjects were randomly assigned to one of the three groups. The baseline characteristics of the subjects in each group are presented in Table 1 .
For body mass index (BMI) the inclusion criterion was p35 kg/m 2 and for age it was 30-65 years. The inclusion criterion for fasting plasma glucose was p8 mmol/l, for B-GHbA1c p8%, for serum concentrations of total cholesterol o7.5 mmol/l and for total triacylglycerols (TG) o4 mmol/l. The subjects without diagnosed DM2 participated in an oral glucose tolerance test. Those with normal fasting and 2 h plasma glucose concentrations (p6 and o7.8 mmol/l, respectively) were excluded. So, subjects with IGT and IFG were included. Subjects with lipid-lowering medication, oral hypoglycemic medication or insulin treatment were excluded. Subjects with unstable angina, history of myocardial infarction, coronary artery bypass graft, percutaneous transluminal coronary angioplasty within the past 6 months, transient ischemic attacks or malignancy were excluded as well. The subjects were not allowed to use any nutrient supplements during the intervention or within 1 month of the beginning of the intervention.
The subjects gave their written informed consent, and the study protocol was approved by the Ethical Committee of the Hospital District of Northern Savo.
Study design
The study was a placebo-controlled, randomized, parallel double-blinded study. The length of the intervention period was 12 weeks. Fiber enrichment was consumed as a drink. The daily dose was 4 dl (containing 16 g fiber per day), which was ingested as two 2 dl portions with main meals. During the first week of the intervention, the subjects consumed only half of the daily dose (2 dl). The subjects were given nutrition counseling by a nutritionist aiming to meet the generally recommended dietary goals for the prevention of cardiovascular diseases and DM2 (DNSG, 2000; NCEP, 2001) . The subjects met a clinical nutritionist at the visits of 0, 2, 4 and 8 weeks. The nutrition counseling concentrated on the modification of the quality of fat and increasing the intake of Sugar beet pectin and polydextrose U Schwab et al dietary fiber. The diet counseled was eucaloric and active weight loss was not an aim. The subjects in the SBP group consumed a drink enriched in SBP obtained from Danisco Sugar (Helsinki, Finland and Nakskov, Denmark). The PDX group consumed a drink enriched in PDX formed by Danisco Sweeteners (Helsinki, Finland and Nakskov, Denmark). The market product of PDX is known as Litesse s . The control group consumed a drink without fiber enrichment. All the drinks had the same ingredients: water, fructose 70 g/l, sodium bentsoate 0.11 g/l, potassium sorbate 0.23 g/l and citric acid 0.5 g/l. Artificial flavor was raspberry in the SBP drink and blackcurrant in the PDX and control drinks. The SBP drink contained 40 g/l SBP of which 76% was soluble fiber and the PDX drink contained 40 g/l PDX. The drinks were produced by Trensums food AB (Tingsryd, Sweden).
The subjects visited the research unit at the beginning of the study (0 week) and four times during the intervention: at 2, 4, 8 and 12 weeks. Body weight was measured at each visit. Blood pressure, concentrations of plasma glucose, plasma insulin and serum total and lipoprotein lipids, oxidized Lowdensity lipoprotein (LDL), and GHbA1 c proportion were measured at 0-, 4-, 8-and 12-week visits. Blood hemoglobin, hematocrit, leukocytes, thrombocytes, liver enzymes, serum sodium, potassium and calcium were measured at 0-, 4-and 12-week visits.
Postprandial glycemia was examined in 24 volunteers (eight subjects from each group) at the beginning and at the end of the intervention period (0 and 12 weeks, respectively) after a standardized breakfast ingested after a 12-h overnight fast. The content of the breakfast was 40 g white bread, 40 g cucumber, 160 g orange juice and 2 dl drink consumed during the intervention. Blood samples were drawn and a visual analogue scale was filled just before the ingestion of the breakfast (0 min) and five times after the ingestion of the breakfast (at 15, 30, 60, 120 and 180 min) .
The subjects kept a 4-day food record just before the intervention to monitor their habitual diet and to enable individual nutrition counseling. During the intervention period, the subjects kept 4-day food records during the third and seventh weeks. The food records were calculated using the Micro-Nutrica s dietary analysis software based on Finnish food analyses and international food composition tables (Rastas et al., 1997) .
The subjects also filled a questionnaire of the appearance of side effects in gastro-intestinal tract at 0-, 4-and 12-week visits. Changes in feelings of thirst were also monitored.
Methods
Body weight was measured using the same calibrated electronic scale throughout the study. Blood pressure was measured from right arm after 5 min of rest in the sitting position using a mercury sphygmomanometer. Two measurements were performed 5 min apart. The mean of these two measurements was used for further analyses.
All venous blood samples were drawn after an overnight fast (12 h). For the analysis of serum total and lipoprotein lipid concentrations, samples were ultracentrifuged for 18 h at the density of 1.006 kg/l to remove very low-density lipoprotein (VLDL). High-density lipoprotein in the infranate was separated from LDL by precipitation of LDL with dextran sulfate and magnesium chloride (Penttilä et al., 1981) . Low-density lipoprotein-cholesterol concentration was calculated as the difference between the mass of cholesterol in the infranate and HDL. Enzymatic colorimetric methods with commercial kits (cholesterol: CHOD-PAP, triglyceride GPO-PAP; Roche Diagnostics GmbH, Mannheim, Germany) were used to determine cholesterol and TG concentrations from whole serum and separated lipoproteins with an automated instrument (Kone Specific Clinical Analyzer, Kone Ltd, Espoo, Finland).
Plasma glucose concentration was analyzed using the glucose dehydrogenase method (Granutest 500, Merck KGaA, Darmstadt, Germany). Plasma insulin concentration was analyzed with a radioimmunoassay (RIA) method (Phadeseph Insulin RIA 100, Pharmacia Diagnostics, Uppsala, Sweden).
The proportion of B-GHbA1 c , plasma concentrations of Cpeptide, sodium, potassium and calcium as well as serum concentrations of gamma-glutamyl transferase (g-GT), alanine aminotransferase (ALT), asparagine aminotransferase (ASAT), alkaline phosphatase (ALP), thyroid-stimulating hormone (TSH) and creatinine were analyzed using the methodology currently in use at the Kuopio University Hospital, Kuopio, Finland.
The concentration of oxidized LDL was measured as the baseline level of conjugated dienes in lipids extracted from LDL (Ahotupa et al., 1996) .
The visual analogue scale used to evaluate the feelings of hunger, satiety, fullness and desire to eat during the postprandial test was based on the publication by Flint et al. (2000) .
The laboratory personnel were unaware of the randomization group during the intervention period and laboratory analyses.
Statistical analyses
The data were analyzed with the SPSS/PC þ statistics program (V11.0, SPSS, Chicago, IL, USA). Before further analyses, normal distribution of the variables was checked with the Kolmogorov-Smirnov test with Lilliefors significance correction. Variables with abnormal distribution (TG, HDL-cholesterol and GHbA1 c ) were log-transformed and the log-values were used in further analyses. The postprandial area under the curve (AUC) of plasma glucose, insulin and Cpeptide was calculated using a Canvas software (v. 6.0, Deneba Systems Inc., Miami, FL, USA). Two-factor repeated measures ANOVA (GLM in SPSS) was used to test the changes within time and group, and to examine the interaction between time and group. Paired samples t-test was used for two-tailed comparisons within the groups. Student's t-test was used for between-group comparisons. Friedman's test and Wilcoxon matched-pairs signed-ranks test were used to test the changes in variables that did not become normal by log-transformation. All data are expressed as mean7s.d. P-level o0.05 was considered as statistically significant.
Results
Dietary intake
There were favorable changes in the intake of fat, especially in the intake of saturated fat, carbohydrates, fiber and cholesterol in all groups ( Table 2 ). The intake of fat, saturated fat and dietary cholesterol decreased, whereas the intake of carbohydrates and dietary fiber increased.
Body weight and blood pressure There were small but significant decreases (Po0.05) in body weight and BMI in the control and PDX groups (Table 3) . Systolic blood pressure decreased significantly in the SBP group and diastolic blood pressure decreased significantly in the control group and in the SBP group (Table 3) .
Plasma glucose concentration and proportion of glycosylated HbA1 c
Fasting plasma glucose concentration did not change in the intervention groups, but increased significantly (Po0.05) in the control group (Table 4) . However, the proportion of GHbA1c increased marginally but statistically significantly in the intervention groups with no change in the control group.
Serum total and lipoprotein lipids, and oxidized LDL There were no significant changes in serum total cholesterol concentration in either of the intervention groups, but there was a significant (Po0.05) decrease in the control group. Serum HDL-cholesterol concentration increased significantly in the intervention groups, whereas serum LDLcholesterol concentration decreased significantly in the control and PDX groups. Furthermore, total to HDLcholesterol ratio decreased significantly in all groups (Table 5 ). There were no changes in the concentration of serum total triglycerides. Concentration of oxidized LDL or the ratio of oxidized LDL to total cholesterol did not change during the study in any of the groups (data not shown).
Postprandial glycemia
There were no differences in AUC of plasma glucose, Cpeptide or insulin between or within the groups during the study. Area under the curve of plasma glucose was 2.171.5 vs 2.671.6 mmol/l min in the control group, 2.370.9 vs 2.972.6 mmol/l min in the PDX group and 2.270.9 vs 3.272.9 mmol/l min in the SBP group (0 week vs 12 weeks, respectively). In the visual analogue scale, no differences were found between or within the groups in the feeling of Sugar beet pectin and polydextrose U Schwab et al hunger, satiety, fullness or desire to eat except that there was a significant (Po0.05) difference in the feeling of hunger at 180 min within the PDX group (6.073.6 vs 3.372.5, 0 week vs 12 weeks, respectively) (data not shown).
Other blood samples There were no changes in hematocrit or blood concentrations of hemoglobin, leukocytes or thrombocytes (data not shown). Neither were there any changes in plasma concentrations of sodium, potassium or calcium or serum concentrations of liver enzymes (g-GT, ASAT, ALT or ALP) or creatinine during the study (data not shown).
Discussion
The subjects of the present study had either a diet-treated type 2 diabetes or they were at high risk of developing diabetes owing to an abnormal glucose metabolism (IGT or IFG). Increased intake of soluble fiber has been found to improve glucose homeostasis and postprandial glucose metabolism (Fuessl et al., 1987; Groop et al., 1993) . Guar gum is the most widely studied form of soluble fiber. In the present study, the effects of PDX and SBP were studied. Polydextrose, trade name Litesse s , is a glucose polymer poorly absorbed by mammals, and it is widely used by food industry. It is readily soluble in water. However, unlike other soluble fibers, there is no gel formation by PDX in water (Oku et al., 1991; Murphy, 2001) . Sugar beet pectin contains 73% dietary fiber (non-starch polysaccharides) of which onethird is water-soluble fiber, mainly pectin.
The subjects received nutrition counseling concentrating on the intake of fat, carbohydrates and dietary cholesterol as well as the quality of fat. Although active weight loss was not an aim, there was a small but significant decrease in body weight in the PDX and control groups, whereas no change was found in the SBP group. However, there were no significant differences in body weight between the groups. Sugar beet pectin and polydextrose U Schwab et al
The fasting concentration of plasma glucose did not change in the PDX and SBP groups, but increased in the control group. In previous studies, guar gum (Aro et al., 1981; Fuessl et al., 1987; Groop et al., 1993) as well as other sources of soluble fiber (Vuksan et al., 1999; Chandalia et al., 2000; Pins et al., 2002) have been reported to result in either a significant or a nonsignificant decrease in blood or plasma glucose concentrations. There were no significant differences in GHbA1c between the groups. However, it increased slightly in the SBP and PDX groups. The drinks were asked to be ingested with main meals. This together with the increased intake of fructose during the intervention might play a role, although according to the most recent recommendations the intake of fructose up to 30 g/day appears to have no deleterious effects on concentrations of plasma insulin or serum total and lipoprotein lipids in subjects with DM2 (Mann et al., 2004) . The daily dose (4 dl) of the drink contained 28 g fructose. In animal studies, increased intake of fructose has been found to cause insulin resistance or worsen existing insulin resistance (Blakely et al., 1981) . In humans, the metabolic effect of increased fructose intake is not clear (Elliott et al., 2002) . Hallfrisch et al. (1983) have found that a diet containing 15% of energy as fructose has detrimental effects on glucose metabolism both in normal and hyperinsulinemic men. Reduced insulin sensitivity and insulin binding to its receptors has also been reported (BeckNielsen et al., 1980) . There were no significant differences between the groups in serum total or lipoprotein lipid concentrations. Serum LDL-cholesterol concentration decreased in the PDX and control groups. The concentration of HDL-cholesterol increased in both SBP and PDX groups, whereas the total to HDL-cholesterol ratio decreased in all groups without a difference among groups. The increase of HDL-cholesterol is usually difficult to achieve by dietary means except by weight loss. An increase of HDL-cholesterol concentration by 0.03 mmol/l has been estimated to decrease the mortality owing to atherosclerosis by 2-3% (von Eckardstein et al., 2001) . In this study, HDL-cholesterol concentration increased significantly by 0.07 mmol/l in both PDX and SBP groups, however, without a significant difference as compared with the control group. Previous studies have shown a small decrease by soluble fiber in serum total and LDL-cholesterol concentrations without a decreasing effect on HDL-cholesterol (Brown et al., 1999; Knopp et al., 1999; Anderson et al., 2000; Vuksan et al., 2000) . Regarding concentrations of serum triglycerides, the results are controversial; in some studies dietary fiber has been shown to have no effect on the concentration of serum triglycerides (Vuksan et al., 1999 (Vuksan et al., , 2000 , whereas in some other studies a decreasing effect of dietary fiber has been reported (Chandalia et al., 2000) . The most commonly reported negative effect of fructose on serum lipid profile has been the increased concentration of serum triglycerides (Bantle et al., 2000) . This effect was not seen in the present study.
According to previous studies, the effect of soluble fiber on blood pressure is controversial. A decreasing effect on systolic blood pressure has been found in some (Vuksan et al., 1999; Pins et al., 2002) but not all studies (Vuksan et al., 2000) . In the present study, systolic blood pressure decreased in the SBP group only (6 mm Hg). The DASH Study (Dietary Approaches to Stop Hypertension) resulted in 3.5 mm Hg loss in normotensives and 11.4 mm Hg loss in hypertensives. Diastolic blood pressure decreased significantly and quite substantially in the SBP and control groups (6 and 5 mm Hg, respectively). In the DASH Study, the magnitude of the decrease of diastolic blood pressure was 2.1 mm Hg in normotensives and 5.5 mm Hg in hypertensives (Svetkey et al., 1999) . In the control group, the decrease in diastolic blood pressure might be partly explained by weight loss.
There were no differences in postprandial concentrations of plasma glucose, insulin or C-peptide among the groups. In previous studies, PDX has been reported to have an acute decreasing effect on glucose absorption in rats. However, the intestine seems to adapt to its effect (Yoshioka et al., 1996) . There are no previous studies in SBP, but guar gum has been found to attenuate postprandial glycemia (Uusitupa et al., 1984) . A confounding factor in the present study might have been the relatively high fructose intake per day. High fructose intake has been reported to lower circulating insulin concentrations (Elliott et al., 2002; Teff et al., 2004) . In fact, fructose seems to be very poor in stimulating insulin secretion (Bray et al., 2004) . In addition to lowered postprandial serum insulin concentration, fructose also seems to attenuate postprandial serum leptin and ghrelin concentrations (Teff et al., 2004) . As serum insulin and leptin concentrations have a key role in the regulation of eating, this may explain why there were no differences in the feelings of hunger, satiety, fullness and desire to eat in this study.
In summary, in subjects with abnormal glucose metabolism, SBP and PDX do not have positive effect on fasting or postprandial plasma glucose concentrations or plasma lipid profile.
